NextFin News - Oura Inc., the Finnish maker of the smart ring that turned sleep and recovery tracking into a mainstream wellness habit, has filed for an initial public offering in the United States — and its financials tell a more unusual story than the headline loss suggests. For the nine months ended June 30, 2026, Oura reported revenue of $1.21 billion, up 74% from $697.6 million a year earlier, and a net loss attributable to common stockholders of $924.3 million. Strip out a $985 million non-cash charge tied to its pre-IPO capital structure, however, and the company earned $60.8 million in net income on $71.2 million of operating profit, with gross margin expanding 3.5 percentage points to 54.5%. The filing, made with the Securities and Exchange Commission on September 3, 2026, reframes the question investors must answer: not whether a hardware company can ever make money, but whether Oura's membership engine is growing fast enough to justify a valuation that reports have placed above $16 billion.
The numbers in the registration statement reward a second look. Total revenue of $1.21 billion for the nine months ended June 30 breaks into $974.0 million of hardware sales and $240.5 million of membership revenue. Hardware grew 65% year over year; membership grew 121%. Membership now accounts for 19.8% of revenue, up from 15.6% in the same period a year earlier — a mix shift that matters because recurring subscription dollars carry far higher margins than titanium rings.
The loss that dominates the headlines is an accounting artifact. The filing shows a "deemed dividend to holders of redeemable convertible preferred stock" of $985.0 million — a non-cash charge that arises from the terms of private financing rounds and is recognized as a loss to common stockholders. It accounts for roughly 106% of the reported $924.3 million net loss. Before that charge, Oura posted net income of $60.8 million, compared with $1.6 million a year earlier. The per-share loss of $89.53 is a function of that charge and a share count that the IPO will reset, not a measure of cash burned.
Oura's path to this filing began with a confidential submission announced in May, when the company said it was on track to surpass five million paid members in the second quarter of 2026 — a fourfold increase over the prior two years. Revenue has scaled in step: $500 million in 2024, about $1 billion in 2025, and a company projection of close to $2 billion for 2026. The nine-month figure of $1.21 billion implies a run-rate above $1.6 billion and is consistent with that guidance. Last fall the company said it had sold 5.5 million rings since its 2015 launch, with nearly 3 million of those sales coming in 2025 alone.
"We've evolved beyond tracking to deliver actionable health intelligence that helps people better understand their bodies and make more informed decisions for their long-term health," said Tom Hale, Oura's chief executive officer, in a company statement. "The company has invested gross profit back into the business to build out artificial intelligence in its products, expand global distribution and develop new health features."
The company says it has plowed gross profit back into the business — and the income statement shows where. Sales and marketing expense rose 84% to $257.9 million, research and development rose 105% to $206.8 million, and general and administrative rose 132% to $126.3 million. Total operating expenses grew 100%, outpacing gross profit growth of 86%, which is why operating margin compressed to 5.9% from 8.6% even as operating income rose to $71.2 million. That is the signature of a company choosing growth over near-term profit maximization — and it is the tension public investors will price.
Oura last raised capital in October 2025, selling $900 million of Series E preferred stock at an $11 billion valuation, bringing total funding to more than $1.5 billion. Reports in August suggested the company was eyeing a public valuation above $16 billion — a bar that requires the market to believe the membership story, not the hardware story.
The membership engine is the real product
The most important line in the filing is not revenue. It is the 121% growth in membership revenue. Oura is attempting something that most hardware companies talk about and few achieve: converting a one-time device sale into a recurring relationship.
The mechanism is a flywheel with a physical entry point. The ring — priced at several hundred dollars — is the acquisition device. It funds inventory, distribution, and marketing, and it lands on the customer's finger. The membership, at $5.99 a month or $69.99 a year in the US, unlocks more than 50 health metrics and the analytics that turn raw sensor data into sleep, readiness, and activity scores. The company reports that 80% of members renew after the first year. Each renewal is high-margin, requires no new manufacturing, and compounds on an installed base that grew fourfold in two years.
That structure explains the financial shape of the filing. Hardware revenue still dominates — $974 million versus $241 million — but membership is growing almost twice as fast and is the reason gross margin expanded even as the company scaled. Over time, if membership continues to outgrow hardware, the revenue mix shifts toward the higher-margin stream and operating leverage improves. This is the software-multiple argument in physical form.
The catch is that the flywheel only spins if the ring keeps selling. Hardware is capital-intensive and inventory-risky in a way that subscription revenue is not. If device sales slow — because the addressable market saturates, because a competitor cuts prices, or because a tech giant bundles a rival tracker into an existing ecosystem — the fixed costs of the subscription business do not shrink with them. Oura's margin of safety is the renewal rate, and 80% is strong but not unassailable. A drop of even a few points would force a rethink of how much of the business deserves a software valuation.
Why the loss is real and also misleading
The $924.3 million net loss is not fake. It is the GAAP number, and it is the number that will appear in every headline. But it is also a distorted lens on the underlying business.
The deemed dividend charge exists because of how Oura's preferred shares were structured. When a company issues redeemable convertible preferred stock with certain terms, accounting rules can require it to recognize a charge against retained earnings — effectively a transfer of value to preferred holders — that flows through as a loss to common stockholders. It is non-cash. It is tied to a capital structure that the IPO is designed to clean up. And at $985 million, it is larger than the company's entire nine-month revenue.
This distinction is the difference between two investment theses. The bearish read stops at the headline: "Oura lost nearly a billion dollars." The more careful read separates the capital-structure charge from operations: revenue up 74%, gross margin expanding, operating income positive, net income positive before the deemed dividend. Public investors will price the business on operating cash generation and the path to sustained GAAP profitability, not on an accounting entry that largely disappears when preferred shares convert at listing.
The danger is the opposite error — assuming the charge is purely cosmetic and ignoring the spending behind it. Operating expenses doubled. Sales and marketing grew faster than hardware revenue. General and administrative more than doubled. Even excluding the deemed dividend, this is a company spending aggressively to buy growth. The question is whether that spending builds durable capacity — brand, distribution, data advantages — or purchases members who churn the moment marketing budgets tighten. The filing shows a company that is operationally profitable today; it does not prove that profitability survives a growth slowdown.
The market is bigger than the research firms say — or smaller than Oura needs it to be
Here is the tension that defines the valuation. Third-party research firms estimate the global smart-ring market at roughly $500 million in 2026, growing at about 26% a year toward $2 billion to $2.5 billion by 2033. Oura alone expects to generate close to $2 billion in revenue in 2026.
The bearish reading is unforgiving: the research numbers are the reliable ones, the category is niche, and Oura has already captured a dominant share of a small pond. Growth from here must come from outside the ring entirely — from watches, bands, enterprise wellness, or health services. A $16-billion-plus valuation on a company that owns a $500-million market is difficult to underwrite no matter how good the retention.
The bullish reading is that the research firms are measuring hardware shipments at average selling prices and missing the subscription layer. The true "smart-ring economy" — device plus recurring membership — is several times larger than reported, and still early. Oura's revenue exceeding the category estimate is not evidence of saturation; it is evidence that the category is being defined too narrowly. A $500-million hardware market cannot support a company doing $1.21 billion in nine-month revenue unless that company is monetizing something beyond the device. That is precisely Oura's argument: the ring is the entry point; the membership is the product.
Both readings are partially right, which is why the competitive landscape matters more than the market-size table. Samsung's Galaxy Ring legitimized the form factor for Android users in 2024. Google re-entered the screenless-tracker space with a new Fitbit device. Whoop raised $575 million in March 2026 at a $10.1 billion valuation and is also heading toward public markets. Garmin is an entrenched player in performance wearables. And Apple, though not yet a ring maker, owns the wrist and the health-data relationship for a large share of Oura's most likely customers. If the real market is "continuous health tracking," Oura competes with every watch, band, and phone on the planet — and with companies that can bundle a tracker at zero marginal price.
Cyclical or structural — the call
The cyclical forces are easy to name. Consumer electronics demand moves with disposable income. The IPO window opens and closes with interest rates and risk appetite. A $16-billion-plus valuation sets a high bar that a weak market could force down — and a discounted pricing would leave the $11-billion private round looking generous. If Oura prices below its last private valuation, early investors will call it bad timing, and they would not be wrong.
The structural forces run deeper. Continuous, passive health monitoring is not a fad that reverts to a mean. It is a change in how consumers relate to their bodies — from episodic, clinician-led measurement to always-on, self-tracked data. The ring form factor solves a problem the watch did not: it tracks sleep, temperature, and recovery without a screen, without daily charging anxiety, and without the social signaling of a wrist device. That is a durable product insight, not a cycle.
The structural case rests on three pillars. First, retention: an 80% first-year renewal rate is behavioral lock-in, not a promotional spike. Second, the revenue model: subscription revenue compounding on an installed base is structurally different from one-off hardware sales, and membership revenue is growing at 121% versus hardware's 65%. Third, the data asset: years of longitudinal sleep, temperature, and readiness data create a product-improvement loop a new entrant cannot replicate quickly.
The cyclical case rests on one pillar: the spending. Operating expenses doubled while operating margin compressed. If the growth is being bought rather than earned, it will revert when budgets tighten. But the spending is being directed at distribution, R&D, and AI features — capacity that persists — rather than at discounting hardware to move inventory. So the verdict: the revenue engine is structural; the valuation and the IPO window are cyclical. An investor who believes the membership base keeps compounding can look through a bad pricing quarter. An investor who believes the ring is a fashion cycle will see the $924-million loss and walk away.
What happens next turns on three variables: the IPO price, the pace of membership additions, and the subscription share of revenue.
In the short term, the stock will trade on sentiment and positioning. Oura is part of a 2026 IPO wave that has drawn other large private companies into the public market. If it prices near or above a $16-billion valuation, the debut will be judged against that ambition; a discounted pricing would signal caution but could set up a stronger aftermarket. Neither the price range nor the share count is in the current filing, and both will be the first real signal of how the market is pricing the membership story.
In the medium term, the quarterly rhythm matters. The metrics to watch are paid-member additions, the 80% renewal rate, membership revenue as a percentage of total revenue, and hardware gross margin. If membership keeps growing at triple-digit rates and its share of revenue climbs toward a quarter of the total, the software-multiple argument strengthens. If hardware sales stall while operating expenses stay elevated, the loss narrative — deemed dividend or not — returns.
"Oura's continued growth, especially at this scale, not only highlights the strength and durability of our business, but also the size of the preventative health market we are competing for," said David Shuman, chairman of Oura's board of directors.
In the long term, the question is whether Oura becomes a preventive-health platform or remains a premium wellness accessory. The company's footprint — more than 4,600 retail locations and partnerships with over 1,200 organizations across health, wellness, and commercial brands — points toward distribution depth that a niche brand does not build. The upside case is a company at the center of employer wellness and insurance-linked health programs. The downside case is a well-designed ring squeezed between Apple's ecosystem and Samsung's Android reach.
The signal that would falsify the structural thesis is specific and observable: if paid-member growth decelerates to low single digits quarter over quarter while the renewal rate falls below 70%, the flywheel has stalled and the subscription multiple collapses. Until then, the burden is on skeptics to prove that continuous health tracking is cyclical — and the data so far says it is not.
Oura's IPO is not really a bet on rings. It is a bet that consumers will pay every month, for years, to keep looking at a small light on their finger — and that a hardware company can be valued like a software one if the renewals hold.
Explore more exclusive insights at nextfin.ai.
